Anlon Healthcare

Anlon Healthcare OCF Margin

The Operating Cash Flow Margin of Anlon Healthcare (AHCL.NS) as of Nov 16, 2026 is -46.20 %. In the previous year, Operating Cash Flow Margin was -18.75 % — a change of 146.40% (lower).

OCF Margin

-46.20 %

YoY

146.40%

Last updated:

Operating Cash Flow Margin of Anlon Healthcare is 2026 -46.20 % . Operating Cash Flow Margin of Anlon Healthcare was 2025 -18.75 % . It decreases by 146.40% lower compared to the previous year.

The Anlon Healthcare OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2022
-3.07 INR
Jan 1, 2023
-2.52 INR
Jan 1, 2024
-4.85 INR
Jan 1, 2025
-18.75 INR
Jan 1, 2026
-46.20 INR
The Anlon Healthcare OCF Margin history
YEAROCF MarginYoY
-46.20 %+146.40%
-18.75 %+286.96%
-4.85 %+91.91%
-2.52 %-17.75%
-3.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Anlon Healthcare Stock analysis

What does Anlon Healthcare do? Anlon Healthcare Ltd. generates revenue through the production and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), nutraceutical APIs, and ingredients for personal care and veterinary applications. Its product portfolio includes 3-(1-cyanoethyl) benzoic acid (CEBA), ketoprofen ethyl ester (KEE), Dex-Ketoprofen, Loxoprofen Acid, Ketoprofen, Silodosin, Omeprazole, L-Arginine, Piroctone olamine, Ticagrelor, and other specialized compounds. The company targets pharmaceutical manufacturers, nutraceutical producers, and personal care and veterinary product developers as its primary customers, serving the broader healthcare and wellness industry segments. The business model focuses on supplying high-quality chemical compounds used in the formulation of medicines and health-related products. Anlon Healthcare Ltd. leverages its expertise in chemical synthesis to deliver tailored solutions for clients in the pharmaceutical sector, ensuring compliance with industry standards. Its product range supports diverse applications, from human medicine to veterinary care and personal care products, enabling it to serve multiple market segments with a single production infrastructure. Revenue streams are derived from direct sales of its chemical products to manufacturers across pharmaceutical, nutraceutical, personal care, and veterinary industries. The company's offerings are designed to meet the specific needs of these sectors, with products like Omeprazole for gastrointestinal treatments and Ticagrelor for cardiovascular care. By providing essential raw materials, Anlon Healthcare Ltd. positions itself as a critical supplier within the healthcare supply chain. Anlon Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Anlon Healthcare stock

Operating Cash Flow Margin of Anlon Healthcare is -46.20 % in 2026.

Operating Cash Flow Margin of Anlon Healthcare changed from -18.75 % to -46.20 %, representing a 146.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Anlon Healthcare since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Anlon Healthcare with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Anlon Healthcare

All Key Metrics — Anlon Healthcare